Novartis skin cancer drug combo bags EC approval for type of melanoma
Novartis has secured approval from the European Commission (EC) for its skin cancer drug combo Tafinlar (dabrafenib) and Mekinist (trametinib)
Continue reading
Tag: European Union
Janssen bags EC approval for daratumumab for multiple myeloma
Janssen Pharmaceutical Companies of Johnson & Johnson has secured marketing authorization for its monoclonal antibody Darzalex (daratumumab) from the European
Continue reading
